Dysphagia Cafe Blog

Evidence Based PracticeHead Neck CancerTreatment

Reva Barewal, DDS, MS, Dipl. ABDSMOctober 21, 2019

Xerostomia: Dysphagia’s evil twin sister

Acute CareEvidence Based PracticeRehabilitation

Kristin King, PhD, CCC-SLPOctober 14, 2019

Tracheostomy tube cuff considerations: Impact, management, and purpose

Evidence Based Practice

Rebecca Bowen, M.A. CCC-SLPSeptember 22, 2019

Finding the best evidence fast

Coffee Break

Julia Kuhn, MS CCC-SLPSeptember 1, 2019

The Guide To Travel Therapy 2019

AssessmentEvidence Based PracticeTreatment

Ed Bice, M.Ed., CCC-SLPSeptember 1, 2019

Modifying more than diets: Rethinking a common practice

Art & Science

Luis Riquelme, PhD, CCC-SLP, BCS-SAugust 18, 2019

Random thoughts on leadership

Podcasts

Dysphagia CafeAugust 14, 2019

SLP Wine (Beer) and Cheese Podcast

Acute CareEvidence Based PracticeRehabilitation

Maribel Ciampitti, M.S. CCC-SLPJuly 28, 2019

Impact of mechanical ventilation on swallowing: Early Intervention-A speech-language pathologist’s perspective

Coffee Break

Dysphagia CafeJuly 27, 2019

SLP knowledge and opinions about breastfeeding: A Student survey

Advocacy

Tia Bagan, M.S. CCC-SLPJune 11, 2019

Speech language pathology: Maintaining balance as a compassionate scientist

From Neuroplasticity to Recovery: The Science and Clinical Application of Pharyngeal Electrical Stimulation (PES)

Elastic Taping in Head & Neck Lymphedema Bundle

Re-Framing the Utility of the Clinical Swallowing Evaluation

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.

Type To Search